Code Description CPT
48160 Pancreatectomy, total or subtotal, with autologous transplantation of pancreas or pancreatic islet cells
HCPCS
G0341 Percutaneous islet cell transplant, includes portal vein catheterization and infusion
G0342 Laparoscopy for islet cell transplant, includes portal vein catheterization and infusion
G0343 Laparotomy for islet cell transplant, includes portal vein catheterization and infusion
S2102 Islet cell tissue transplant from pancreas; allogeneic
Islet Transplantation
Introduction
The pancreas is an organ that stretches lengthwise across the abdominal area below the stomach. Within the pancreas are cell clusters commonly called “the islets.” Included in the islets are beta cells which make, store, and release insulin. Treating chronic inflammation of the pancreas may mean removing the pancreas. Removing the pancreas also removes the islets and the beta cells, which then leads to type 1 diabetes. To prevent the development of type 1 diabetes in people who have their pancreas removed, their own islet cells can be harvested and injected into a specific vein in the liver. Published medical studies show that islet cell transplantation appears to significantly decrease the development diabetes after the pancreas is removed. In this situation, islet cell transplantation may be considered medically necessary. Islet cell transplantation using donor cells is being studied as a technique to treat existing type 1 diabetes. There is not enough medical evidence to show how well this works to treat type 1 diabetes. Larger and longer studies are needed. For these reasons, islet cell transplantation to treat existing type 1 diabetes is investigational (unproven).
Note: The Introduction section is for your general knowledge and is not to be taken as policy coverage criteria. The rest of the policy uses specific words and concepts familiar to medical professionals. It is intended for providers. A provider can be a person, such as a doctor, nurse, psychologist, or dentist. A provider also can be a place where medical care is given, like a hospital, clinic, or lab. This policy informs them about when a service may be covered.
Policy Coverage Criteria
Procedure Medical Necessity Autologous pancreas islet transplantation
Autologous pancreas islet transplantation may be considered medically necessary as an adjunct to a total or near total pancreatectomy in patients with chronic pancreatitis.
Procedure Investigational
Allogeneic islet transplantation
Islet transplantation, all other
Documentation Requirements
Allogeneic islet transplantation is considered investigational for the treatment of type 1 diabetes. Islet transplantation is considered investigational in all other situations.
The patient’s medical records submitted for review for all conditions should document that medical necessity criteria are met. The record should include the following: * Office visit notes that contain the relevant history and physical:
o Patient had pancreas removed because of chronic pancreatitis
Guidelines Nationally Covered Indications
Whole organ pancreas transplantation is nationally covered by Medicare when performed simultaneous with or after a kidney transplant. If the pancreas transplant occurs after the kidney transplant, immunosuppressive therapy begins with the date of discharge from the inpatient stay for the pancreas transplant.
Pancreas transplants alone (PA) are reasonable and necessary for Medicare beneficiaries in the following limited circumstances:
• PA will be limited to those facilities that are Medicare-approved for kidney transplantation. Approved centers can be found at Approved Transplant Programs
• Patients must have a diagnosis of type I diabetes:
* Patient with diabetes must be beta cell autoantibody positive; or
* Patient must demonstrate insulinopenia defined as a fasting C-peptide level that is less than or equal to 110% of the lower limit of normal of the laboratory's measurement method. Fasting C-peptide levels will only be considered valid with a concurrently obtained fasting glucose ≤ 225 mg/dL;
• Patients must have been optimally and intensively managed by an endocrinologist for at least 12 months with the most medically-recogni
zed advanced insulin formulations and delivery systems;
•Patients must have a history of medically -uncontrollable labile (brittle) insulin-dependent diabetes mellitus with documented recurrent, severe, acutely life-threatening metabolic complications that require hospitalization.
Aforementioned complications include frequent hypoglycemia unawareness or recurring severe ketoacidosis, or recurring severe hypoglycemic attacks;
• Patients must have the emotional and mental capacity to understand the significant risks associated with surgery and to effectively manage the lifelong need for immunosuppression; and,
• Patients must otherwise be a suitable candidate for transplantation.
If a kidney and pancreas transplants are performed simultaneously, the claim should contain a diabetes diagnosis code and a renal failure code or one of the hypertensive renal failure diagnosis codes. The claim should also contain two transplant procedure codes. If the claim is for a pancreas transplant only, the claim should contain a diabetes diagnosis code and a status code to indicate a previous kidney transplant. If the status code is not on the claim for the pancreas transplant, UnitedHealthcare will search the beneficiary's claim history for a status code indicating a prior kidney transplant.
CPT Code Description
48160 Pancreatectomy, total or subtotal, with autologous transplantation of pancreas or pancreatic islet cells (Not covered by Medicare)
48554 Transplantation of pancreatic allograft (CMS sourced)
ICD- 10 Procedure Code Description
0FYG0Z0 Transplantation of pancreas, alloge neic, open approach (CMS sourced)
0FYG0Z1 Transplantation of pancreas, syngeneic, open approach (CMS sourced)
Blue Cross and Blue Shield Association Islet Cell Transplantation Billing /Coding/Physician Documentation Information
Applicable service codes:
48160, 48999, G0341, G0342, G0343, S2102
BCBSNC may request medical records for determination of medical necessity. When medical records are requested, letters of support and/or explanation are often useful, but are not sufficient documentation unless all specific information needed to make a medical necessity determination is included.
Coding
Evidence Review
Description
Performed in conjunction with pancreatectomy, autologous islet transplantation is proposed to reduce the likelihood of insulin-dependent diabetes. Allogeneic islet cell transplantation is being investigated as a treatment or cure for patients with type 1 diabetes.
Background Chronic Pancreatitis
Primary risk factors for chronic pancreatitis may be categorized as the following: toxicmetabolic, idiopathic, genetic, autoimmune, recurrent and severe acute pancreatitis, or obstructive (TIGAR-O classification system). Patients with chronic pancreatitis may experience intractable pain that can only be relieved with a total or near total pancreatectomy. However, the pain relief must be balanced against the certainty that the patient will be rendered an insulin-dependent diabetic.
Type 1 Diabetes
Glucose control is a challenge for individuals with type 1 diabetes. Failure to prevent disease progression can lead to long-term complications such as retinopathy, neuropathy, nephropathy, and cardiovascular disease.
Islet Transplantation
In autologous islet transplantation during the pancreatectomy procedure, islet cells are isolated from the resected pancreas using enzymes, and a suspension of the cells is injected into the portal vein of the patient’s liver. Once implanted, the beta cells in these islets begin to make and release insulin.
Allogeneic islet transplantation potentially offers an alternative to whole-organ pancreas transplantation. In the case of allogeneic islet cell transplantation, cells are harvested from a deceased donor’s pancreas, processed, and injected into the recipient’s portal vein. Up to 3 donor pancreas transplants may be required to achieve insulin independence. However, a limitation of islet transplantation is that 2 or more donor organs are usually required for successful transplantation, although experimentation with single-donor transplantation is occurring. A pancreas that is rejected for whole-organ transplant is typically used for islet transplantation. Therefore, islet transplantation has generally been reserved for patients with frequent and severe metabolic complications who have consistently failed to achieve control with insulin-based management. Allogeneic transplantation may be performed in the radiology department.
In 2000, a modified immunosuppression regimen increased the success of allogeneic islet transplantation. This regimen is known as the “Edmonton protocol.”
Medicare denial codes, reason, remark and adjustment codes.Medicare, UHC, BCBS, Medicaid denial codes and insurance appeal. Sample appeal letter for denial claim. CO, PR and OA denial reason codes codes.
Pages
- Home
- Medicare denial code - Full list - Description
- Healthcare policy identification denial list - Most common denial
- Medicare appeal - Most commonly asked questions ?
- TOP 6 CODING ERRORS - Humana
- Medicare No claims/payment information FAQ
- Top Six tips to avoid insurance denial
- How insurance identifying duplicate claim - proces...
- Rejection code 34538, 36428, 39929,76474, c7010 - solution
Sunday, May 19, 2019
Subscribe to:
Post Comments (Atom)
Popular Posts
-
MCR - 835 Denial Code List PR - Patient Responsibility - We could bill the patient for this denial however please make sure that any oth...
-
Locating PLBs • Provider-level adjustments can increase or decrease the transaction payment amount. • Adjustment codes are located in P...
-
BCBS insurance denial codes differ state to state and we could not refer one state denial code to other denial. Here we have list some of th...
-
Claim appeal If you believe you were underpaid by us, the first step in resolving your concern is to submit a Claim Reconsideration as d...
-
PROVIDER ADJ DETAILS The provider-level adjustment details section is used to show adjustments that are not specific to a particular cla...
-
CPT Code and Definitions 36415 Collection of venous blood by venipuncture 36416 Collection of capillary blood specimen (e.g., finger, hee...
-
Medicare contractors are permitted to use the following group codes: CO Contractual Obligation (provider is financially liable); CR Co...
-
CO 97 Payment adjusted because this procedure/service is not paid separately. Explanation: • The benefit for this service ...
-
Medicaid Claim Denial Codes N1 - N50 N1 You may appeal this decision in writing within the required time limits following receipt of...
-
MCR - 835 Denial Code List CO : Contractual Obligations - Denial based on the contract and as per the fee schedule amount. CO should ...
No comments:
Post a Comment